  - Synthetic Genomics spins out agri-biotech company Agradis
San Diego-based Synthetic Genomics has formed an agricultural biotechnology company that will focus on developing natural products to boost crop production. The new company, Agradis, will initially work on producing improved crops through genomics and it will use microorganisms to develop crop-protection and growth products. Agradis was able to raise $20 million in initial funding. San Diego Business Journal (10/25)        | John Jantsch invites you to go local
As customers continue to rely on the Web to help them screen local businesses, local businesses must take steps to ensure that they pop to the top of online searches. Duct Tape Marketing's John Jantsch offers strategies for local marketing success in this free white paper from American Express OPEN, How to Win at the Local Marketing Game. Download your free copy now, exclusively for SmartBrief readers. |
 - Study links 3 genotypes to blood clots in stent patients
Three genotypes related to Plavix and platelet functions may trigger blood clots in patients who received heart stent implants, researchers at the Paris-based Pitie-Salpetriere Hospital found. The use of information about a person's genetic profile may help providers better assess blood clot risks, but more studies are needed to determine whether treatment adjustments should be made on this basis, experts said. Reuters (10/24) - Experts ID gene variants associated with leprosy
Mutations in the IL23R gene, which was previously associated with psoriasis and ulcerative colitis, may also play a role in the development of leprosy, a study revealed. Researchers also found that the RAB32 gene may be behind autophagy in infected patients. The findings were published in Nature Genetics. GenomeWeb Daily News (10/24)  | Are you keeping up with the changing world of employee health care? Get The Basics of Employee Health Care for Small Business: A Guide to Creating a Company Benefit Plan, and find out what you need to know today. There's no obligation. Click to download a complimentary whitepaper. |
 - COO Meeker is chosen as Genzyme's CEO
David Meeker, Genzyme's chief operating officer, was selected as CEO of the Sanofi division. Meeker will oversee business for rare-disease and multiple sclerosis drugs and report to Sanofi CEO Chris Viehbacher. Xconomy/Boston (10/24) - Newron regains safinamide rights from Merck Serono
Merck Serono returned rights to safinamide, an experimental Parkinson's disease medicine, to Newron Pharmaceuticals. Safinamide has "a more limited market potential than originally anticipated," said Merck Serono. The firms will continue working on another Parkinson's drug candidate, sarizotan, and insomnia treatment pruvanserin. InPharm.com (10/24)  | Tokenization is more than a security measure and more than a cost savings technique. It can be used to build your business. This white paper discusses the ways tokens can be used in back-end business operations to develop powerful marketing programs. |
 - Monsanto allots $2.2M to aid Australian cotton farmers
Monsanto has donated more than $2.2 million to assist cotton growers in Australia who were affected by last summer's floods. Cotton Australia, which set up the fund, said it has put in place an independent company to ensure that the funds, to be used for crop planting this season, are distributed properly. ABC (Australia) (10/25)  | FREE TRIAL – Thomson Reuters Cortellis™ Pipeline Intelligence
Discover new opportunities in drug development and licensing faster. Cortellis gives you an innovative way of finding and acting on drug pipelines, deals, patents, companies, breaking industry news, and conference coverage in one source, intuitively presented.
Click here to see if you qualify for a free trial! |
| Industrial & Environmental |  |  | | - Study: Separating corn stover boosts cellullosic ethanol output
A group of researchers at Purdue University has determined that separating corn stover's rind, pith and leaves could improve the efficiency of cellulosic ethanol production, according to a report in the journal Biotechnology and Bioengineering. "We show that there are major differences in degradability among the tissues," said one of the researchers. Processing the rinds requires at least 10 times more enzymes but increases yields by just 20%, pushing up production cost, the researcher added. Hoosier Ag Today (Clermont, Ind.) (10/24) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is saving 2,700 companies nationwide on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot, Business Wire are just a few of the industry leading providers that offer special pricing through this members only program. Learn more or enroll here.
| SmartQuote | | | |  | Never bend your head. Always hold it high. Look the world straight in the eye."
--Helen Keller,
American author and political activist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, October 24, 2011
- Friday, October 21, 2011
- Thursday, October 20, 2011
- Wednesday, October 19, 2011
- Tuesday, October 18, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment